NuCana (NCNA) Shares Outstanding (2017 - 2025)

NuCana's (NCNA) quarterly Shares Outstanding came in at $27.7 billion in Q4 2025, up 15083.66% year-on-year from N/an in Q4 2024, and up 15083.66% quarter-over-quarter from $182.3 million in Q4 2024.

NuCana (NCNA) Shares Outstanding (2017 - 2025) Analysis & Trends

NuCana has disclosed Shares Outstanding across 9 years of filings, most recently posting $27.7 billion for Q4 2025.

  • Shares Outstanding for Q4 2025 came in at $27.7 billion, up 15083.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $27.7 billion (up 15083.66% YoY), and the FY2025 annual result was $27.4 billion, up 15012.14% from the prior year.
  • Shares Outstanding came in at $27.7 billion for Q4 2025 at NuCana, up from $182.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $27.7 billion in Q4 2025 to a low of $61.4 million in Q4 2022.
  • The 5-year median for Shares Outstanding is $70.3 million (2021), against an average of $5.6 billion.
  • Across the five-year window, Shares Outstanding decreased 12.67% in 2022 and surged 15083.66% in 2025, its largest moves.
  • NuCana's Shares Outstanding stood at $70.3 million in 2021, then decreased by 12.67% to $61.4 million in 2022, then gained by 6.8% to $65.6 million in 2023, then soared by 177.87% to $182.3 million in 2024, then soared by 15083.66% to $27.7 billion in 2025.
  • The last three Shares Outstanding figures came in at $27.7 billion (Q4 2025), $182.3 million (Q4 2024), and $65.6 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 40.14 Bn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 91.57 Bn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1.88
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 254.16 Mn
9 Abivax 94.26 Bn 94.26 Bn - -
10 NuCana 29.13 Bn 29.13 Bn - 27.68 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 27.68 Bn
Dec 31, 2025 27.68 Bn
Dec 31, 2025 27.68 Bn
Dec 31, 2025 27.68 Bn
Dec 31, 2025 27.68 Bn
Dec 31, 2025 27.68 Bn
Dec 31, 2025 27.68 Bn
Dec 31, 2025 27.68 Bn
Dec 31, 2024 182.31 Mn
Dec 31, 2024 182.31 Mn
Dec 31, 2024 182.31 Mn
Dec 31, 2024 182.31 Mn
Dec 31, 2024 182.31 Mn
Dec 31, 2024 182.31 Mn
Dec 31, 2024 182.31 Mn
Dec 31, 2024 182.31 Mn
Dec 31, 2023 65.61 Mn
Dec 31, 2023 65.61 Mn
Dec 31, 2023 65.61 Mn
Dec 31, 2023 65.61 Mn